STARTUP PROFILE

Neuro42

COUNTRY
USA
FOUNDED
2020
CATEGORY
Neuroimaging
Building FDA-cleared portable, robotic and AI-driven MRI platforms that bring real-time neuroimaging and interventional guidance directly to patients.
Visit website →
Neurofounders Insights
$   Funding   -
Series A
MODALITY
(f)MRI
FORM FACTOR
Imaging system
INTERFACE DEPTH
Non-invasive
INDICATION
Head injury
TARGET USER
Clinicians
REGULATORY STAGE
FDA cleared (510k)
neuro42 is differentiated by combining portable MRI with robotics and AI, targeting bedside imaging and interventional guidance rather than conventional radiology throughput. Its ambition is significant, though execution requires mastering both hardware complexity and hospital integration.
Mentioned in Market Notes
MOST RECENT COVERAGE
No items found.
Articles featuring
Neuro42
No items found.